DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LEVOMILNACIPRAN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Levomilnacipran Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00969150	Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder	Completed	Forest Laboratories	Phase 3	The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder.
NCT00969709	Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder	Completed	Forest Laboratories	Phase 3	The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER fixed doses versus placebo in the treatment of outpatients with major depressive disorder.
NCT01034462	Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder	Completed	Forest Laboratories	Phase 3	The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER versus placebo in the treatment of outpatients with major depressive disorder
NCT01254305	Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder	Completed	Forest Laboratories	Phase 2	The purpose of the study is to evaluate the efficacy, safety and tolerability of Levomilnacipran ER for the treatment of fatigue associated with major depressive disorder (MDD).
NCT01377194	Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder	Completed	Forest Laboratories	Phase 3	The purpose of this study is to evaluate the efficacy, safety, and tolerability of Levomilnacipran ER compared to placebo in patients with Major Depressive Disorder (MDD).

Clinical Trial Conditions for Levomilnacipran Hydrochloride

Condition Name

Condition Name for Levomilnacipran Hydrochloride
Intervention	Trials
Major Depressive Disorder	8
Tobacco Use Disorder	1
Major Depressive Disorder (MDD)	1
Depressive Disorder, Major	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Levomilnacipran Hydrochloride
Intervention	Trials
Depressive Disorder, Major	10
Depressive Disorder	10
Depression	10
Disease	8

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Levomilnacipran Hydrochloride

Trials by Country

Trials by Country for Levomilnacipran Hydrochloride
Location	Trials
United States	141
Canada	3
Puerto Rico	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Levomilnacipran Hydrochloride
Location	Trials
New York	8
California	8
Illinois	8
Georgia	7
Texas	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Levomilnacipran Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Levomilnacipran Hydrochloride
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	8
Phase 2	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Levomilnacipran Hydrochloride
Clinical Trial Phase	Trials
Completed	5
Recruiting	3
Not yet recruiting	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Levomilnacipran Hydrochloride

Sponsor Name

Sponsor Name for Levomilnacipran Hydrochloride
Sponsor	Trials
Forest Laboratories	8
Allergan	1
Duke University	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Levomilnacipran Hydrochloride
Sponsor	Trials
Industry	9
Other	4

Export unavailable in trial.
Subscribe for complete access.